Cranbury, NJ · Founded 2015 · Privately Held (backing)
Developer of topical drugs designed for applications in ophthalmology, dermatology, and otolaryngology. iView Therapeutics is based in Cranbury, NJ and was founded in 2015. It was valued at $107 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $39.2 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in May 2024.
PMV mark · valuation
$107.4M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$39.2M
Last round
Early Stage VC
May 2024
Cap table — not yet on record
iView Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of iView Therapeutics with a free account
·The complete investor list: 16 names
·Watch iView Therapeutics: the Monday email on marks, rounds and moves
Where does iView Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across iView Therapeutics's 2 recorded funding rounds.
